| Stage | URI | % of rev | APO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $4.9B | 100.00% | $11.2B | 100.00% | APO ×2.28 |
| Gross profit | $2.0B | 41.81% | $10.2B | 91.69% | APO +49.9pp |
| Operating income | $1.4B | 28.80% | $2.4B | 21.63% | URI +7.2pp |
| Pre-tax income | $1.2B | 25.16% | $2.5B | 22.28% | URI +2.9pp |
| Net income | $920M | 18.80% | $2.1B | 18.73% | URI +0.1pp |
| Stage | URI | APO | Gap · A − B |
|---|---|---|---|
| Revenue | $4.9B100.00% | $11.2B100.00% | APO ×2.28 |
| Gross profit | 41.81%$2.0B | 91.69%$10.2B | APO +49.9pp |
| Operating income | 28.80%$1.4B | 21.63%$2.4B | URI +7.2pp |
| Pre-tax income | 25.16%$1.2B | 22.28%$2.5B | URI +2.9pp |
| Net income |
| 18.80%$920M |
| 18.73%$2.1B |
| URI +0.1pp |